86 related articles for article (PubMed ID: 17110616)
1. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity.
Brown WM; Maxwell P; Graham AN; Yakkundi A; Dunlop EA; Shi Z; Johnston PG; Lappin TR
Stem Cells; 2007 Mar; 25(3):718-22. PubMed ID: 17110616
[TBL] [Abstract][Full Text] [Related]
2. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
4. Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.
Kirkeby A; van Beek J; Nielsen J; Leist M; Helboe L
J Neurosci Methods; 2007 Aug; 164(1):50-8. PubMed ID: 17524492
[TBL] [Abstract][Full Text] [Related]
5. Anti-Epo receptor antibodies do not predict Epo receptor expression.
Elliott S; Busse L; Bass MB; Lu H; Sarosi I; Sinclair AM; Spahr C; Um M; Van G; Begley CG
Blood; 2006 Mar; 107(5):1892-5. PubMed ID: 16249375
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of erythropoietin receptor in human pterygial tissues.
Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
[TBL] [Abstract][Full Text] [Related]
7. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the inducible heat shock protein hsp70: a methodological study.
Malusecka E; Zborek A; Krzyzowska-Gruca S; Krawczyk Z
J Histochem Cytochem; 2006 Feb; 54(2):183-90. PubMed ID: 16204226
[TBL] [Abstract][Full Text] [Related]
9. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
10. Impaired downregulation following erythropoietin receptor activation in non-small cell lung carcinoma.
Dunlop EA; Maxwell AP; Lappin TR
Stem Cells; 2007 Feb; 25(2):380-4. PubMed ID: 17038666
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
13. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
14. Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma.
Malusecka E; Krzyzowska-Gruca S; Gawrychowski J; Fiszer-Kierzkowska A; Kolosza Z; Krawczyk Z
Anticancer Res; 2008; 28(1B):501-6. PubMed ID: 18383892
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T; Xu C; He M; Sun Y
Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
[TBL] [Abstract][Full Text] [Related]
16. Dimerization of the erythropoietin receptor transmembrane domain in micelles.
Ebie AZ; Fleming KG
J Mol Biol; 2007 Feb; 366(2):517-24. PubMed ID: 17173930
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma.
Li HG; Li JS; Chen WL; Wang L; Wu DH; Lin ZY
Br J Oral Maxillofac Surg; 2009 Sep; 47(6):470-5. PubMed ID: 19559511
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin receptors on tumor cells: what do they mean?
Fandrey J
Oncologist; 2008; 13 Suppl 3():16-20. PubMed ID: 18458120
[TBL] [Abstract][Full Text] [Related]
19. Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation.
Maxwell P; Melendez-Rodríguez F; Matchett KB; Aragones J; Ben-Califa N; Jaekel H; Hengst L; Lindner H; Bernardini A; Brockmeier U; Fandrey J; Grunert F; Oster HS; Mittelman M; El-Tanani M; Thiersch M; Schneider Gasser EM; Gassmann M; Dangoor D; Cuthbert RJ; Irvine A; Jordan A; Lappin T; Thompson J; Neumann D
Br J Haematol; 2015 Feb; 168(3):429-42. PubMed ID: 25283956
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
